SABS·78397T103·UQ·equity·Healthcare - Biotechnology-Activist
SABS (SAB BIOTHERAPEUTICS INC) is held by 30 institutional investors as of Q4 2025. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($16.5M), Woodline Partners LP ($10.7M), Blackstone Inc. ($8M). Net institutional sentiment: Bullish.
Showing 5 of 30 results.25 more with Pro.PROUpgrade to see all → |
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer